The Abilitech team is excited to be participating in the TCMx9 accelerator program hosted by Texas Medical Center and Johnson & Johnson Labs this August through October. With the guidance of influential advisors and sponsors, we are growing and developing alongside industry leaders. We are excited to take advantage of this opportunity to explore new funding potential and product development channels for our Abilitech™ Assist (FDA registration 2020) and future suite of products.

Skip to content